ALEXANDRIA KIRIAN: Open Payments
NPI 1174242119 · BAYBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$340 in 17 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $85 · 2025 $340
Food & beverage: $340
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 4 | $80 |
| TOLMAR, INC. | 2 | $51 |
| GlaxoSmithKline, LLC. | 2 | $45 |
| Lilly USA, LLC | 2 | $38 |
| Amgen Inc. | 2 | $29 |
| Novo Nordisk Inc | 2 | $27 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $26 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
Products named: REXULTI, JATENZO, XIFAXAN, SHINGRIX, JARDIANCE, TRELEGY ELLIPTA, VOQUEZNA, AUSTEDO XR.
Industry payments across NC — which companies pay providers there.
